A new installment of my series Materia Medica Illuminated -

Ignatia amara (Strychnos ignatia), & the taxonomy of grief.

Ignatia is a well-known remedy in the homeopathic Materia Medica, an early introduction by Hahnemann often considered one of our polychrests; remedies "of many uses." Yet its use is often stereotyped as a "grief" remedy, or even trivially as "the grief remedy."

In this 2-hour online session, we'll look closely at Ignatia, using a variety of tools & strategies for effective Materia Medica study, including my "remedy map" of Ignatia and a differential study of grief and other dimensions of Ignatia's pathogenesis. I'll begin our study with a case, focusing on its analysis with attention to differentiating Ignatia from other leading & small remedies suggested by the totality of characterizing symptoms.

This is part of my ongoing online series Materia Medica Illuminated, with several installments currently available in recorded format for self-paced participation.

Please join me for the Live Session on Wednesday October 4 2017, from 4:30-6:30pm US Pacific time (UTC-7).

$30 for 2 hours of homeopathic continuing education, for live session access, including 6 months access to all course materials with streaming video of the recorded live session for review or self-paced participation.

Will Taylor M.D.


Cypripedium pubescensIn this single 2-hour online session,

held Wednesday September 6; 4:30-6:30pm US Pacific Time (UTC-7), and available as a self-paced course via streaming video afterwards,

we'll investigate a "small," poorly-described, relatively neglected remedy (Will refers to these as "Rodney Dangerfield remedies," as they don't get much respect), after identifying this as the Silillimum to a case we consider.  We'll look closely at the strategies employed in case analysis to pluck this out of a field of much better-known remedies, and will explore strategies for accessing information about "small" remedies, including knowledge of the most effective resources for reading about these.

We'll closely investigate the remedy Cypripedium pubescens (Cypripedium parviflorum var. pubescens, the yellow lady slipper of northern North America), developing a "map" of this remedy from a study of its description in our literature, and reflecting on a couple of cases in which it proved curative; and will extend our investigation to the discussion of the study, and identification in casework, of "small" remedies in general, bringing a few of these into focus.

One 2-hour online session, via Live interactive webinar, Wednesday Sepember 5; 4:30-6:30pm US Pacific Time (UTC-7).  See the FAQs page on my site if you have questions re how these courses work, technical requirements &c.  Participants will have access to all course materials, including streaming video of the live session posted after it airs, for 6 months following registration. 

Following your registration via PayPal (using either a PayPal account, or a credit/debit card transaction processed by PayPal (you do not need a PayPal account to do this) you'll be directed to the course support page, where you'll find a link to register with our webinar service provider for the Live Session.


Hyoscyamus nigerOn reading the existing materia medica descriptions of Hyoscyamus, it would appear difficult to prescribe this remedy outside of cases of extreme insanity, delirium, or severe neurological pathologies; and although we may find usefulness for it in those rare cases of such that we may encounter, this is a remedy useful as well in many more day-to-day presentations.  

In this one-session, 2-hour presentation & discussion, Will will develop his materia medica "map" of Hyoscyamus, discussing this remedy in the context of existing descriptions in our classical materia medica, and cases from Will's own clinical experience as well as our classical literature; we'll also examine some of the rubrics listing Hyoscyamus in our Repertories, with some discussion of important differentials with other remedies found in those rubrics, and describe "similar" and important "related" remedies, including some examination of the utility and shortfalls of examining this from a "families" perspective as a member of the botanical family Solanacea and other taxonomic and analogic groupings in which it might be classified.

Hyoscyamus was one of the earliest remedies introduced by Hahnemann, and was one of the most thoroughly-described of the 27 medicinal substances included in his early 1805 collection 'Fragmenta de viribus medicamentorum positivis..'.  Study of this plant as a medicinal agent by Hahnemann's medical school teacher Anton von Störck, in Vienna, may have been instrumental in Hahnemann's recognition of cure by similars as a principle of cure.

Presented as a live 2-hour Webinar session with the opportunity for participant questions, comments & discussion supplemented by an online course support page with downloadable handout, asynchronous discussion forum, self-review & participation-assessment quiz, and downloadable document of participation.  The Live session will be recorded & posted on the course support page for review & self-paced participation for those unable to attend the live session.  Enrollment will provide 6-months' access to all course materials.


Thursday, January 19, 4-6pm US Pacific standard time (UTC-8)

- click here for time & date in your timezone -

Instant enrollment via the PayPal link below:

Materia Medica Illuminated

(Strychnos) Nux vomica

William Boericke described Nux vomica as "the greatest of polychrests, because the bulk of its symptoms correspond in similarity with those of the commonest and most frequent of diseases."

One of the earliest substances introduced to the homeopathic materia medica, we find Hahnemann listing 308 pathogenic symptoms of Nux vomica among the 27 medicinal substances described in his first collection of Prüfungen ("provings"), his1805 'Fragmenta de viribus medicamentorum positivis sive in sano corpore humano observatis'

We'll embark on an in-depth study of (Strychos) Nux vomica, investigating its use in both acute and chronic homeopathic cases, in this next installment of Materia Medica Illuminated, while simultaneously cultivating effective approaches to materia medica study in general.

a 2-hour online continuing education offering from the Academy for Homeopathic Studies, with Will Taylor, MD.

Thursday, January 7, 5-7pm US Pacific time (UTC-8)
(click here to view time & date in your time zone)

Immediate enrollment via the PayPal link below (accepting a credit or debit card, or a PayPall account)

BelladonnaUsually one of the first remedies introduced when studying homeopathy - 

but why leave it at that?

We'll embark on an in-depth study of Atropa belladonna, investigating its use in both acute and chronic homeopathic cases, in this next installment of Materia Medica Illuminated.

a single 2-hour online continuing education offering from the Academy for Homeopathic Studies, with Will Taylor, MD.

Initially aired Thursday December 10 2015; now available for self-paced participation via streaming video of the recorded live session.


Sepia officinalisSepia was introduced to homeopathic practice by Hahnemann in his Chronic Diseases as an "antipsoric," and has found a place among our most valued polychrests - well-known remedies of many uses.  Its use in practice however is often limited by trivialized descriptions and stereotyping as a "women's remedy," a characterization which may limit our ability to recognize its applicability in other settings and result in its overprescription in gynecologic concerns.

In this free webinar session we'll engage in a careful study of Sepia, tapping resources from our classical literature and contemporary cases, building up a visual/textual "map" of this invaluable remedy and discussing important contrasts & comparisons with other "large" and "small" remedies.

Join Will for this free 2-hour webinar, presented live with provision for discussion both during the live session, and subsequently via an asynchronous online forum.  Self-paced participation will be available via streaming video of the recorded live session, supplemented by access to the discussion forum, for those unable to attend live, and will be available to all course participants - live and self-paced -  for 6 months from the date of registration.

Documentation will be provided for 2 hours of Homeopathic Continuing Education for all course participants.

Enrollment is FREE, via the "enroll me" link below.

sulphurrecorded in live session on January 28, this course is now available in streaming video (in an .rtmp true stream for FLASH-enabled devices [normal Mac, Windows and Linux computers], and .html pseudostream for iOS & Android mobile devices) for self-paced participation.


In this one-session course, we'll look closely at Hahnemann's great antipsoric remedy, using several approaches to organize our understanding of its pathogenesis, and examining cases both acute and chronic in which it has acted curatively.

Sulphur is often the first remedy introduced in the study of homeopathy - and yet it is often remains the most enigmatic of our remedies, with a coherent understanding  often very difficult to grasp.  Kent tells us that the neophyte will prescribe a good deal of Sulphur, and the seasoned practitioner will prescribe a good deal of Sulphur; the difference will be in whom they prescribe it to.  I used to recoil at the prospect of teaching Sulphur; my training provided a good understanding of many of its particulars, but my appreciation of its coherent pathogenesis was lacking until I began looking at it through the organized methods of study that this course will introduce.

2 hour live online presentation, with downloadable handout and supporting materials; Wednesday January 28th, 2015, 5-7pm US Pacific time.

The video recording of the live presentation will be posted for review and for those unable to attend the live presentation.  Your registration will provide 6 months' access to all course materials.

Registration is automatic through PayPal, below.

If you have questions about how this all works, or regarding the technical requirements for participation, please see the homstudies.com FAQs page.

Will Taylor.M.D. | willtaylor@homstudies.com